Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration

Download these slides from an expert-led symposium on the use of BTK inhibitors in the frontline treatment of CLL/SLL.

Susan M. O'Brien, MD Released: December 9, 2022

Download these slides from an expert-led symposium on the use of BTK inhibitors in relapsed/refractory CLL/SLL.

Jeff Sharman, MD
Program Director Released: December 9, 2022

Download these slides from an expert-led symposium on BTK inhibitors for the treatment of mantle cell lymphoma.

Ian W. Flinn, MD, PhD Released: December 9, 2022

Download these slides from an expert-led symposium on current and emerging BTK inhibitors for chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma.

Ian W. Flinn, MD, PhD Released: December 9, 2022

Download this short summary slideset of key takeaways from a live symposium on BTK inhibitors in CLL and MCL.

Jeff Sharman, MD
Program Director Ian W. Flinn, MD, PhD Susan M. O'Brien, MD Released: December 16, 2022

Watch this on-demand webcast from an ASH satellite symposium on the use of novel BTK inhibitors for patients with CLL and MCL, including discussions on current and emerging BTK inhibitors and combinations, treatment for frontline and relapsed/refractory CLL/SLL and MCL, toxicity management, and ongoing clinical trials.

Jeff Sharman, MD
Program Director Ian W. Flinn, MD, PhD Susan M. O'Brien, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: January 31, 2023 Expired: January 30, 2024